These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20655962)

  • 1. Novel strategies and approaches to develop the next generation of vaccines against porcine reproductive and respiratory syndrome virus (PRRSV).
    Huang YW; Meng XJ
    Virus Res; 2010 Dec; 154(1-2):141-9. PubMed ID: 20655962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction.
    Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM
    Vaccine; 2015 Aug; 33(33):4069-80. PubMed ID: 26148878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: Current status and future direction.
    Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM
    Vaccine; 2015 Jun; 33(27):3065-72. PubMed ID: 25980425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
    Geldhof MF; Vanhee M; Van Breedam W; Van Doorsselaere J; Karniychuk UU; Nauwynck HJ
    BMC Vet Res; 2012 Oct; 8():182. PubMed ID: 23031319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus.
    Sun H; Workman A; Osorio FA; Steffen D; Vu HLX
    Vaccine; 2018 Jan; 36(1):66-73. PubMed ID: 29174314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy evaluation of two commercial modified-live virus vaccines against a novel recombinant type 2 porcine reproductive and respiratory syndrome virus.
    Sun YF; Zhou L; Bian T; Tian XX; Ren WK; Lu C; Zhang L; Li XL; Cui MS; Yang HC; Yu H
    Vet Microbiol; 2018 Mar; 216():176-182. PubMed ID: 29519513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive inductive effect of swine interleukin-4 on immune responses elicited by modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine.
    Peng J; Wang J; Wu J; Du Y; Li J; Guo Z; Yu J; Xu S; Zhang Y; Sun W; Cong X; Shi J
    Viral Immunol; 2013 Dec; 26(6):404-14. PubMed ID: 24328935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs.
    Subramaniam S; Piñeyro P; Derscheid RJ; Madson DM; Magstadt DR; Meng XJ
    Vet Immunol Immunopathol; 2017 Aug; 190():18-25. PubMed ID: 28778318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine reproductive and respiratory syndrome virus vaccines: current status and strategies to a universal vaccine.
    Hu J; Zhang C
    Transbound Emerg Dis; 2014 Apr; 61(2):109-20. PubMed ID: 23343057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two commercially available porcine reproductive and respiratory syndrome virus (PRRSV) modified-live virus vaccines analyzing the growth performance in 1-day-old vaccinated swine located on endemic farms co-circulating PRRSV-1 and PRRSV-2.
    Yang S; Kang I; Jeong J; Oh T; Park KH; Park SJ; Ham HJ; Jin GR; Lee BH; Chae C
    J Vet Med Sci; 2020 Feb; 82(2):224-228. PubMed ID: 31866631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity.
    Chen C; Li J; Bi Y; Yang L; Meng S; Zhou Y; Jia X; Meng S; Sun L; Liu W
    Vaccine; 2013 Apr; 31(14):1838-47. PubMed ID: 23395588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
    Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.
    Kim T; Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
    Clin Vaccine Immunol; 2015 Jun; 22(6):631-40. PubMed ID: 25855554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
    Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
    Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspective.
    Renukaradhya GJ; Dwivedi V; Manickam C; Binjawadagi B; Benfield D
    Anim Health Res Rev; 2012 Jun; 13(1):21-37. PubMed ID: 22717576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
    Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
    Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
    Park C; Choi K; Jeong J; Chae C
    Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.